-
1
-
-
84877028141
-
Comprehensive molecular portraits of human breast tumours
-
Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418): 61-70.
-
(2012)
Nature
, vol.490
, Issue.7418
, pp. 61-70
-
-
-
2
-
-
84905029258
-
Comprehensive molecular profiling of lung adenocarcinoma
-
Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014; 511(7511): 543-50.
-
(2014)
Nature
, vol.511
, Issue.7511
, pp. 543-550
-
-
-
3
-
-
79959838081
-
Integrated genomic analyses of ovarian carcinoma
-
Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474(7353): 609-15.
-
(2011)
Nature
, vol.474
, Issue.7353
, pp. 609-615
-
-
-
4
-
-
84868210526
-
Next-generation sequencing in breast cancer: first take home messages
-
Desmedt C, Voet T, Sotiriou C, Campbell PJ. Next-generation sequencing in breast cancer: first take home messages. Curr Opin Oncol. 2012; 24(6): 597-604.
-
(2012)
Curr Opin Oncol
, vol.24
, Issue.6
, pp. 597-604
-
-
Desmedt, C.1
Voet, T.2
Sotiriou, C.3
Campbell, P.J.4
-
5
-
-
34648821257
-
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
-
Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer. 2007; 7(10): 791-9.
-
(2007)
Nat Rev Cancer
, vol.7
, Issue.10
, pp. 791-799
-
-
Stingl, J.1
Caldas, C.2
-
6
-
-
83755196805
-
BRAF inhibitors and melanoma
-
Flaherty KT. BRAF inhibitors and melanoma. Cancer J. 2011; 17(6): 505-11.
-
(2011)
Cancer J
, vol.17
, Issue.6
, pp. 505-511
-
-
Flaherty, K.T.1
-
7
-
-
84922223009
-
Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
-
Girotti MR, Lopes F, Preece N, Niculescu-Duvaz D, Zambon A, Davies L, Whittaker S, Saturno G, Viros A, Pedersen M, Suijkerbuijk BM, Menard D, McLeary R, Johnson L, Fish L, Ejiama S, Sanchez-Laorden B, Hohloch J, Carragher N, Macleod K, Ashton G, Marusiak AA, Fusi A, Brognard J, Frame M, Lorigan P, Marais R, Springer C. Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma. Cancer Cell. 2015;27(1): 85-96.
-
(2015)
Cancer Cell
, vol.27
, Issue.1
, pp. 85-96
-
-
Girotti, M.R.1
Lopes, F.2
Preece, N.3
Niculescu-Duvaz, D.4
Zambon, A.5
Davies, L.6
Whittaker, S.7
Saturno, G.8
Viros, A.9
Pedersen, M.10
Suijkerbuijk, B.M.11
Menard, D.12
McLeary, R.13
Johnson, L.14
Fish, L.15
Ejiama, S.16
Sanchez-Laorden, B.17
Hohloch, J.18
Carragher, N.19
Macleod, K.20
Ashton, G.21
Marusiak, A.A.22
Fusi, A.23
Brognard, J.24
Frame, M.25
Lorigan, P.26
Marais, R.27
Springer, C.28
more..
-
8
-
-
84921288028
-
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
-
Tomasetti C, Vogelstein B. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015; 347(6217): 78-81.
-
(2015)
Science
, vol.347
, Issue.6217
, pp. 78-81
-
-
Tomasetti, C.1
Vogelstein, B.2
-
9
-
-
84917706145
-
Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition
-
Lamb R, Harrison H, Hulit J, Smith DL, Lisanti MP, Sotgia F. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition. Oncotarget. 2014; 5(22): 11029-37.
-
(2014)
Oncotarget
, vol.5
, Issue.22
, pp. 11029-11037
-
-
Lamb, R.1
Harrison, H.2
Hulit, J.3
Smith, D.L.4
Lisanti, M.P.5
Sotgia, F.6
-
11
-
-
84900560869
-
Evolution of mitochondria reconstructed from the energy metabolism of living bacteria
-
Degli Esposti M, Chouaia B, Comandatore F, Crotti E, Sassera D, Lievens PM, Daffonchio D, Bandi C. Evolution of mitochondria reconstructed from the energy metabolism of living bacteria. PLoS One. 2014; 9(5): e96566.
-
(2014)
PLoS One
, vol.9
, Issue.5
-
-
Degli Esposti, M.1
Chouaia, B.2
Comandatore, F.3
Crotti, E.4
Sassera, D.5
Lievens, P.M.6
Daffonchio, D.7
Bandi, C.8
-
12
-
-
84924219709
-
Doxycycline enhances survival and self-renewal of human pluripotent stem cells
-
Chang MY, Rhee YH, Yi SH, Lee SJ, Kim RK, Kim H, Park CH, Lee SH. Doxycycline enhances survival and self-renewal of human pluripotent stem cells. Stem Cell Reports. 2014; 3(2): 353-64.
-
(2014)
Stem Cell Reports
, vol.3
, Issue.2
, pp. 353-364
-
-
Chang, M.Y.1
Rhee, Y.H.2
Yi, S.H.3
Lee, S.J.4
Kim, R.K.5
Kim, H.6
Park, C.H.7
Lee, S.H.8
-
13
-
-
84878138385
-
Mitonuclear protein imbalance as a conserved longevity mechanism
-
Houtkooper RH, Mouchiroud L, Ryu D, Moullan N, Katsyuba E, Knott G, Williams RW, Auwerx J. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature. 2013; 497(7450): 451-7.
-
(2013)
Nature
, vol.497
, Issue.7450
, pp. 451-457
-
-
Houtkooper, R.H.1
Mouchiroud, L.2
Ryu, D.3
Moullan, N.4
Katsyuba, E.5
Knott, G.6
Williams, R.W.7
Auwerx, J.8
-
14
-
-
0242353929
-
Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines
-
Krakauer T, Buckley M. Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob Agents Chemother. 2003; 47(11):3630-3.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, Issue.11
, pp. 3630-3633
-
-
Krakauer, T.1
Buckley, M.2
-
15
-
-
76749108006
-
Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma-in vitro and in vivo studies
-
Shen LC, Chen YK, Lin LM, Shaw SY. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma-in vitro and in vivo studies. Oral Oncol. 2010; 46(3): 178-84.
-
(2010)
Oral Oncol
, vol.46
, Issue.3
, pp. 178-184
-
-
Shen, L.C.1
Chen, Y.K.2
Lin, L.M.3
Shaw, S.Y.4
-
16
-
-
59449093937
-
Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells
-
Foroodi F, Duivenvoorden WC, Singh G. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.Anticancer Drugs. 2009; 20(2): 115-22.
-
(2009)
Anticancer Drugs
, vol.20
, Issue.2
, pp. 115-122
-
-
Foroodi, F.1
Duivenvoorden, W.C.2
Singh, G.3
-
17
-
-
31344476048
-
Tetracyclines: nonantibiotic properties and their clinical implications
-
Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006; 54(2): 258-65.
-
(2006)
J Am Acad Dermatol
, vol.54
, Issue.2
, pp. 258-265
-
-
Sapadin, A.N.1
Fleischmajer, R.2
-
18
-
-
1542510038
-
Doxycycline and other tetracyclines in the treatment of bone metastasis
-
Saikali Z, Singh G. Doxycycline and other tetracyclines in the treatment of bone metastasis. Anticancer Drugs. 2003; 14(10): 773-8.
-
(2003)
Anticancer Drugs
, vol.14
, Issue.10
, pp. 773-778
-
-
Saikali, Z.1
Singh, G.2
-
19
-
-
0037086271
-
Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer
-
Duivenvoorden WC, Popovic SV, Lhoták S, Seidlitz E, Hirte HW, Tozer RG, Singh G. Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer. Cancer Res. 2002; 62(6): 1588-91.
-
(2002)
Cancer Res
, vol.62
, Issue.6
, pp. 1588-1591
-
-
Duivenvoorden, W.C.1
Popovic, S.V.2
Lhoták, S.3
Seidlitz, E.4
Hirte, H.W.5
Tozer, R.G.6
Singh, G.7
-
20
-
-
71949099927
-
Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells
-
Son K, Fujioka S, Iida T, Furukawa K, Fujita T, Yamada H, Chiao PJ, Yanaga K. Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells. Anticancer Res. 2009; 29(10): 3995-4003.
-
(2009)
Anticancer Res
, vol.29
, Issue.10
, pp. 3995-4003
-
-
Son, K.1
Fujioka, S.2
Iida, T.3
Furukawa, K.4
Fujita, T.5
Yamada, H.6
Chiao, P.J.7
Yanaga, K.8
-
21
-
-
84863686386
-
Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis
-
Rattan R, Ali Fehmi R, Munkarah A. Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis. J Oncol. 2012; 2012: 928127.
-
(2012)
J Oncol
, vol.2012
-
-
Rattan, R.1
Ali Fehmi, R.2
Munkarah, A.3
-
22
-
-
70350236538
-
Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission
-
Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res. 2009; 69(19): 7507-11.
-
(2009)
Cancer Res
, vol.69
, Issue.19
, pp. 7507-7511
-
-
Hirsch, H.A.1
Iliopoulos, D.2
Tsichlis, P.N.3
Struhl, K.4
-
23
-
-
84925490271
-
Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma
-
Oct 24. [Epub ahead of print].
-
Han JJ, Kim TM, Jeon YK, Kim MK, Khwarg SI, Kim CW, Kim IH, Heo DS. Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma. Ann Hematol. 2014 Oct 24. [Epub ahead of print].
-
(2014)
Ann Hematol
-
-
Han, J.J.1
Kim, T.M.2
Jeon, Y.K.3
Kim, M.K.4
Khwarg, S.I.5
Kim, C.W.6
Kim, I.H.7
Heo, D.S.8
-
24
-
-
34748908862
-
A woman and her canary: a tale of chlamydiae and lymphomas
-
Ferreri AJ, Dolcetti R, Magnino S, Doglioni C, Cangi MG, Pecciarini L, Ghia P, Dagklis A, Pasini E, Vicari N, Dognini GP, Resti AG, Ponzoni M. A woman and her canary: a tale of chlamydiae and lymphomas. J Natl Cancer Inst. 2007; 99(18): 1418-9.
-
(2007)
J Natl Cancer Inst
, vol.99
, Issue.18
, pp. 1418-1419
-
-
Ferreri, A.J.1
Dolcetti, R.2
Magnino, S.3
Doglioni, C.4
Cangi, M.G.5
Pecciarini, L.6
Ghia, P.7
Dagklis, A.8
Pasini, E.9
Vicari, N.10
Dognini, G.P.11
Resti, A.G.12
Ponzoni, M.13
-
25
-
-
24644519021
-
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy
-
Ferreri AJ, Ponzoni M, Guidoboni M, De Conciliis C, Resti AG, Mazzi B, Lettini AA, Demeter J, Dell'Oro S, Doglioni C, Villa E, Boiocchi M, Dolcetti R. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol. 2005; 23(22): 5067-73.
-
(2005)
J Clin Oncol
, vol.23
, Issue.22
, pp. 5067-5073
-
-
Ferreri, A.J.1
Ponzoni, M.2
Guidoboni, M.3
De Conciliis, C.4
Resti, A.G.5
Mazzi, B.6
Lettini, A.A.7
Demeter, J.8
Dell'Oro, S.9
Doglioni, C.10
Villa, E.11
Boiocchi, M.12
Dolcetti, R.13
-
26
-
-
84899136540
-
Azithromycin enhances the favorable results of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer
-
Chu DJ, Yao DE, Zhuang YF, Hong Y, Zhu XC, Fang ZR, Yu J, Yu ZY. Azithromycin enhances the favorable results of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer. Genet Mol Res. 2014; 13(2): 2796-805.
-
(2014)
Genet Mol Res
, vol.13
, Issue.2
, pp. 2796-2805
-
-
Chu, D.J.1
Yao, D.E.2
Zhuang, Y.F.3
Hong, Y.4
Zhu, X.C.5
Fang, Z.R.6
Yu, J.7
Yu, Z.Y.8
-
27
-
-
33749569161
-
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial
-
Ferreri AJ, Ponzoni M, Guidoboni M, Resti AG, Politi LS, Cortelazzo S, Demeter J, Zallio F, Palmas A, Muti G, Dognini GP, Pasini E, Lettini AA, Sacchetti F, De Conciliis C, Doglioni C, Dolcetti R. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J Natl Cancer Inst. 2006; 98(19): 1375-82.
-
(2006)
J Natl Cancer Inst
, vol.98
, Issue.19
, pp. 1375-1382
-
-
Ferreri, A.J.1
Ponzoni, M.2
Guidoboni, M.3
Resti, A.G.4
Politi, L.S.5
Cortelazzo, S.6
Demeter, J.7
Zallio, F.8
Palmas, A.9
Muti, G.10
Dognini, G.P.11
Pasini, E.12
Lettini, A.A.13
Sacchetti, F.14
De Conciliis, C.15
Doglioni, C.16
Dolcetti, R.17
-
28
-
-
84865704948
-
A detailed mammosphere assay protocol for the quantification of breast stem cell activity
-
Shaw FL, Harrison H, Spence K, Ablett MP, Simoes BM, Farnie G, Clarke RB. A detailed mammosphere assay protocol for the quantification of breast stem cell activity. J Mammary Gland Biol Neoplasia. 2012; 17(2): 111-117.
-
(2012)
J Mammary Gland Biol Neoplasia
, vol.17
, Issue.2
, pp. 111-117
-
-
Shaw, F.L.1
Harrison, H.2
Spence, K.3
Ablett, M.P.4
Simoes, B.M.5
Farnie, G.6
Clarke, R.B.7
|